Clinical trial reportBloodPublished
Circulating tumor cells predict myeloma outcomes in patients treated with daratumumab, bortezomib, lenalidomide, and dexamethasone
Regional connection
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
- Institution
- Johnson & Johnson
- County
- Montgomery County
Publication record
- Type
- Clinical trial report
- Venue
- Blood
- Published
- Topic
- Disease research
- Subject terms
- Humans; Multiple Myeloma; Dexamethasone; Antineoplastic Combined Chemotherapy Protocols; Antibodies, Monoclonal; Prognosis; Treatment Outcome; Adult; Aged; Middle Aged; Female; Male
- PubMed ID
- 41060326
- PubMed Central ID
- PMC12883856
- Open access
- Yes, open
- Added to directory
- Source checked